Chen Yu, TCGX founder and managing partner
As the biotech funding game changed, TCGX altered course — and now they’re back with $1B for round two
When Chen Yu and his team at TCGX set out in early 2021 with some $800 million to invest in biotech, he …
This article is available only to Premium subscribers
Upgrade to Premium for unlimited access and Premium exclusives.
